MindMaze Therapeutics Holding (RLFTF)

[trademax42]

If true (unofficial info), these two info have massive implications:

1. EUA filed for severely ill patients Sept 17, 2020

2. For inhaled trial.... 6 patients were given inhaler formulation and 6 healed.

The Emergency Use Approval (EUA) of Remdesivir by the FDA added $10 Billion to Gilead's market cap overnight when it was first announced.

The second point bodes well for upcoming inhale formulation trials to be announced shortly. I believe the inhale formulation, if it gets approval, will be a huge money maker for the company.

Those 6 patients came out in a leaked email.....6 out of 6 healed.

$RLFTF

Disclaimer: This is just in my opinion, do your own dd.